Assessment of Alcon's Ocular Image Quantification System

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)

One drop twice daily in each eye for 5 days, followed by an additional drop in each eye prior to allergen test.

OTHER

Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)

One drop twice daily in each eye for 5 days, followed by an additional drop in each eye prior to allergen test.

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY